Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Liao, Pi Hung ^a   Yang, Hui Hua ^a   Chou, Ping Tse ^b   Wang, Ming Hseng ^a   Chu, Po Chun ^c   Liu, Hao Li ^c   Chen, Li Kuang ^a,b  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; Central nerve system; Cerebrospinal fluid; Hypertonic breakdown; Occludin; Passive immunotherapy; Rabies; Virus neutralizing monoclonal antibody

Indexed keywords

ALBUMIN; EVANS BLUE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 8 10E; NEUTRALIZING ANTIBODY; OCCLUDIN; PROTEIN ZO1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RNA; SONOVUE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; ALBUMINOID; TJP1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE TEST; IMMUNOTHERAPY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNOTHERAPY; PRIORITY JOURNAL; RABIES; RABIES VIRUS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; SURVIVAL; ULTRASOUND; VIRUS GENOME; VIRUS NEUTRALIZATION; WESTERN BLOTTING; ANIMAL; CEREBROSPINAL FLUID; HUMAN; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

RABIES VIRUS; RATTUS;

ALBUMINS; ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNOGLOBULIN G; OCCLUDIN; RABIES; RABIES VIRUS; RATS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84865689941     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-61     Document Type: Article

References (51)

1. Expert Consultation on rabies. WHO, World Health Organ Tech Rep Ser 2005 931 1 88 back cover 16485446
2. Therapy of rabies encephalitis. Jackson AC, Biomedica 2009 29 169 176 20128341
3. Overview, prevention, and treatment of rabies. Nigg AJ, Walker PL, Pharmacotherapy 2009 29 1182 1195 10.1592/phco.29.10.1182 19792992
4. Human rabies encephalitis following bat exposure: failure of therapeutic coma. McDermid RC, Saxinger L, Lee B, Johnstone J, Gibney RT, Johnson M, Bagshaw SM, CMAJ 2008 178 557 561 10.1503/cmaj.071326 18299541
5. Case report on fatal human rabies infection in Hamburg, Germany, March 2007. Schmiedel S, Panning M, Lohse A, Kreymann KG, Gerloff C, Burchard G, Drosten C, Schmiedel S, Panning M, Lohse A, Kreymann KG, Gerloff C, Burchard G, Drosten C, Euro Surveill 2007 12 070531 E070535 17868588
6. Failure of therapeutic coma and ketamine for therapy of human rabies. Hemachudha T, Sunsaneewitayakul B, Desudchit T, Suankratay C, Sittipunt C, Wacharapluesadee S, Khawplod P, Wilde H, Jackson AC, J Neurovirol 2006 12 407 409 10.1080/13550280600902295 17065135
7. Human rabies - Indiana and California. MMWR Morb Mortal Wkly Rep 2007 56 361 365 17443120
8. Survival after treatment of rabies with induction of coma. Willoughby RE, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, Chusid MJ, Rupprecht CE, N Engl J Med 2005 352 2508 2514 10.1056/NEJMoa050382 15958806
9. Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. Roy A, Hooper DC, J Virol 2007 81 7993 7998 10.1128/JVI.00710-07 17507463
10. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. Roy A, Phares TW, Koprowski H, Hooper DC, J Virol 2007 81 1110 1118 10.1128/JVI.01964-06 17108029
11. Human rabies - Tennessee. MMWR Morb Mortal Wkly Rep 2002 51 828 829 12353742
12. Human rabies - Minnesota. MMWR Morb Mortal Wkly Rep 2008 57 460 462 18451757
13. Rabies in a nine-year-old child: The myth of the bite. Despond O, Tucci M, Decaluwe H, Gregoire MC, S Teitelbaum J, Turgeon N, Can J Infect Dis 2002 13 121 125 18159381
14. MR imaging in human rabies. Laothamatas J, Hemachudha T, Mitrabhakdi E, Wannakrairot P, Tulayadaechanont S, Am J Neuroradiol 2003 24 1102 1109 12812933
15. Imaging findings in rabies encephalitis. Awasthi M, Parmar H, Patankar T, Castillo M, Am J Neuroradiol 2001 22 677 680 11290477
16. A new approach for multiple sampling of cisternal cerebrospinal fluid in rodents with minimal trauma and inflammation. Huang YL, Saljo A, Suneson A, Hansson HA, J Neurosci Methods 1995 63 13 22 10.1016/0165-0270(95)00080-1 8788043
17. Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity. van den Berg MP, Romeijn SG, Verhoef JC, Merkus FW, J Neurosci Methods 2002 116 99 107 10.1016/S0165-0270(02)00033-X 12007987
18. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. Esen F, Erdem T, Aktan D, Orhan M, Kaya M, Eraksoy H, Cakar N, Telci L, Crit Care 2005 9 18 R23 10.1186/cc3004 15693962
19. Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Rapoport SI, Fredericks WR, Ohno K, Pettigrew KD, Am J Physiol 1980 238 421 R431 7377381
20. Size selectivity of blood-brain barrier permeability at various times after osmotic opening. Robinson PJ, Rapoport SI, Am J Physiol 1987 253 459 R466 2443025
21. Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications. Rapoport SI, Cell Mol Neurobiol 2000 20 217 230 10.1023/A:1007049806660 10696511
22. In vivo assessment of macrophage CNS infiltration during disruption of the blood-brain barrier with focused ultrasound: a magnetic resonance imaging study. Liu HL, Wai YY, Hsu PH, Lyu LA, Wu JS, Shen CR, Chen JC, Yen TC, Wang JJ, J Cerebral Blood Flow Metab 2010 30 674 10.1038/jcbfm.2009.251
23. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Liu HL, Hua MY, Yang HW, Huang CY, Chu PC, Wu JS, Tseng IC, Wang JJ, Yen TC, Chen PY, Wei KC, Proc Natl Acad Sci U S A 2010 107 15205 15210 10.1073/pnas.1003388107 20696897
24. A microtest for the quantitation of rabies virus neutralizing antibodies. Zalan E, Wilson C, Pukitis D, J Biol Stand 1979 7 213 220 10.1016/S0092- 1157(79)80024-4 387798
25. A rapid reproducible test for determining rabies neutralizing antibody. Smith JS, Yager PA, Baer GM, Bull World Health Organ 1973 48 535 541 4544144
26. The blood-brain barrier/neurovascular unit in health and disease. Hawkins BT, Davis TP, Pharmacol Rev 2005 57 173 185 10.1124/pr.57.2.4 15914466
27. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. Phares TW, Kean RB, Mikheeva T, Hooper DC, J Immunol 2006 176 7666 7675 16751414
28. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL, Am J Pathoy 1999 155 1915 1927 10.1016/S0002-9440(10)65511- 3
29. Blood-brain barrier disruption following traumatic brain injury: roles of tight junction proteins. Ng I, Yap E, Tan WL, Kong NY, Ann Acad Med Singapore 2003 32 Suppl 5 63 S66 14968742
30. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. Kirk J, Plumb J, Mirakhur M, McQuaid S, J Pathog 2003 201 319 327
31. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Mark KS, Davis TP, Am J Physiol Heart Circ Physiol 2002 282 1485 H1494 11893586
32. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Brooks TA, Hawkins BT, Huber JD, Egleton RD, Davis TP, Am J Physiol Heart Circ Physiol 2005 289 738 H743 10.1152/ajpheart.01288.2004 15792985
33. Disruption of the blood-brain barrier in collagen-induced arthritic mice. Nishioku T, Yamauchi A, Takata F, Watanabe T, Furusho K, Shuto H, Dohgu S, Kataoka Y, Neurosci Lett 2010 482 208 211 10.1016/j.neulet.2010.07.035 20654699
34. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Nusrat A, Turner JR, Madara JL, Am J Physiol Gastrointest Liver Physiol 2000 279 851 G857 11052980
35. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Huber JD, Egleton RD, Davis TP, Trends Neurosci 2001 24 719 725 10.1016/S0166-2236(00)02004-X 11718877
36. Blood-brain barrier disruption in the treatment of brain tumors. Blanchette M, Fortin D, Methods Mol Biol 2011 686 447 463 10.1007/978-1-60761- 938-3-23 21082387
37. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Rapoport SI, Expert opin investigat drugs 2001 10 1809 1818 10.1517/13543784.10.10.1809
38. Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats. Rousseau V, Denizot B, Pouliquen D, Jallet P, Le Jeune JJ, MAGMA 1997 5 213 222 10.1007/BF02594584 9351025
39. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption. Nilaver G, Muldoon LL, Kroll RA, Pagel MA, Breakefield XO, Davidson BL, Neuwelt EA, Proc Natl Acad Sci U S A 1995 92 9829 9833 10.1073/pnas.92.21.9829 7568227
40. Entry of neutralizing antibody to measles into brain and cerebrospinal fluid of immunized monkeys after osmotic opening of the blood-brain barrier. Hicks JT, Albrecht P, Rapoport SI, Exp Neurol 1976 53 768 779 10.1016/0014-4886(76)90154-0 826403
41. Intracarotid tumor necrosis factor-alpha administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: quantitative aspects of double-labelling studies and confocal laser scanning analysis. Abraham CS, Deli MA, Joo F, Megyeri P, Torpier G, Neurosci Lett 1996 208 85 88 10.1016/0304-3940(96)12546-5 8859896
42. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. Wright JL, Merchant RE, J Neuro-oncol 1994 20 17 25 10.1007/BF01057957
43. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Kinoshita M, McDannold N, Jolesz FA, Hynynen K, Bioche Biophys Res Comm 2006 340 1085 1090 10.1016/j.bbrc.2005.12.112
44. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Kinoshita M, McDannold N, Jolesz FA, Hynynen K, Proc Natl Acad Sci U S A 2006 103 11719 11723 10.1073/pnas.0604318103 16868082
45. Human rabies - Mississippi, 2005. MMWR Morb Mortal Wkly Rep 2006 55 207 208 16511442
46. Delivery of melanoma-associated immunoglobulin monoclonal antibody and Fab fragments to normal brain utilizing osmotic blood-brain barrier disruption. Neuwelt EA, Barnett PA, Hellstrom I, Hellstrom KE, Beaumier P, McCormick CI, Weigel RM, Cancer Res 1988 48 4725 4729 3409213
47. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P, Zimmerman RD, Knopman J, Scheff RJ, Christos P, Vallabhajosula S, Riina HA, Clinical article. J Neurosurg 2011 114 624 632
48. Recent advances in blood-brain barrier disruption as a CNS delivery strategy. Bellavance MA, Blanchette M, Fortin D, AAPS J 2008 10 166 177 10.1208/s12248-008-9018-7 18446517
49. Rabies in the critical care unit: diagnostic and therapeutic approaches. Jackson AC, Can J Neurol Sci 2011 38 689 695 21856570
50. Immunovirological correlates in human rabies treated with therapeutic coma. Hunter M, Johnson N, Hedderwick S, McCaughey C, Lowry K, McConville J, Herron B, McQuaid S, Marston D, Goddard T, Harkess G, Goharriz H, Voller K, Solomon T, Willoughby RE, Fooks AR, J Med Virol 2010 82 1255 1265 10.1002/jmv.21785 20513093
51. Human rabies encephalitis by a vampire bat bite in an urban area of Colombia. Badillo R, Mantilla JC, Pradilla G, Biomedica 2009 29 191 203 20128344